Gt Biopharma Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.80

-0.09 (-1.31%)

As of Sep 28, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +265.4% upside

Low Target $15.48

Average Target $24.85

High Target $31.61

Current Price $6.80

Current
$6.80

Target
$24.85

$15.48 $24.85 avg $31.61

Scenario Analysis

Bear Case

$15.48

127.6%

Low target

Base Case

$24.85

+265.4%

Avg target

Bull Case

$31.61

+364.9%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$34.25

-80.1% from high

52-Week Low

$4.91

+38.5% from low

Target vs 52W High

$24.85

-27.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%